U.S. Senator Richard Shelby (R-Ala.), a senior member of the Senate Appropriations Committee, today announced that the University of Alabama at Birmingham (UAB) has been awarded a five-year grant award totaling $26,879,040 from the National Center for Research Resources, a component of the National Institutes of Health (NIH). This funding, a Clinical and Translational Science Award (CTSA), aims to reduce the time it takes for research discoveries to become new treatments for patients.
“The University of Alabama at Birmingham is one of our nation’s premier research institutions,” said Shelby. “As part of the CTSA consortium, researchers at UAB will work alongside other premier health centers conducting critical studies to provide new, cutting-edge medical treatments to patients. I am confident that the findings from the research that will be conducted at UAB will reach far beyond Alabama and help extend and improve the lives of people across our nation.”
UAB is one of 14 institutions receiving a new CTSA grant this year and joins 23 other academic health centers that have received such funding since 2006. Total funding for these new awards is $533 million over five years. The 2008 CTSA grants expand state representation in the consortium to Alabama, Colorado, Indiana, Massachusetts, and Utah. They also support pediatric research at 13 dedicated children’s hospitals; expand research in genetics and genomics; enhance research in behavioral immunology and infection risk; and increase outreach into local communities.
The CTSA initiative grew out of the NIH commitment to re-engineer the clinical research enterprise, one of the key objectives of the NIH Roadmap for Medical Research. Most of the funding will come from terminating grants to General Clinical Research Centers, supplemented by NIH Roadmap funds. In 2012, when the program is fully implemented, approximately 60 CTSAs will be connected with an annual budget of $500 million. For more information regarding the CTSA program, please visit www.ncrr.nih.gov/crctsa.